Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Maxwell

Showing results (361-370 of 453) with videos related to

Pageof 46
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2024
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)A George, R A Herbertson, A Stillie, et al.
Nature|June 3, 1999
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisP H Maxwell, M S Wiesener, G W Chang, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 15, 2008
Variations within oxygen-regulated gene expression in humansJerome T S Brooks, Gareth P Elvidge, Louisa Glenny, et al.
Nature|June 7, 2002
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHLWai-Ching Hon, Michael I Wilson, Karl Harlos, et al.
Melanoma Research|August 28, 1999
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivoM Fujita, D A Norris, H Yagi, et al.
Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2004
Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardiumJan Steffen Jürgensen, Christian Rosenberger, Michael S Wiesener, et al.
Cell Reports|July 12, 2024
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entryBo Meng, Na Zhao, Petra Mlcochova, et al.
Molecular and Cellular Biology|June 21, 2005
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaRaju R Raval, Kah Weng Lau, Maxine G B Tran, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Pre-radiotherapy multidisciplinary survivorship care and patient-reported outcomes in head and neck cancer survivorsFendi Obuekwe, Jinhong Li, Susan M Sereika, et al.
Pageof 46

Showing results (361-370 of 453) with videos related to

Sort By:
Pageof 46
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2024
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)A George, R A Herbertson, A Stillie, et al.
Nature|June 3, 1999
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisP H Maxwell, M S Wiesener, G W Chang, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 15, 2008
Variations within oxygen-regulated gene expression in humansJerome T S Brooks, Gareth P Elvidge, Louisa Glenny, et al.
Nature|June 7, 2002
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHLWai-Ching Hon, Michael I Wilson, Karl Harlos, et al.
Melanoma Research|August 28, 1999
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivoM Fujita, D A Norris, H Yagi, et al.
Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2004
Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardiumJan Steffen Jürgensen, Christian Rosenberger, Michael S Wiesener, et al.
Cell Reports|July 12, 2024
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entryBo Meng, Na Zhao, Petra Mlcochova, et al.
Molecular and Cellular Biology|June 21, 2005
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaRaju R Raval, Kah Weng Lau, Maxine G B Tran, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Pre-radiotherapy multidisciplinary survivorship care and patient-reported outcomes in head and neck cancer survivorsFendi Obuekwe, Jinhong Li, Susan M Sereika, et al.
Pageof 46